ArriVent BioPharma, Inc. AVBP Debt-to-assets
Debt-to-assets at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s debt-to-assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s debt-to-assets?
- ArriVent BioPharma, Inc. (AVBP) reported debt-to-assets of 0× in Q1 2026.
- How has ArriVent BioPharma, Inc.'s debt-to-assets changed year-over-year?
- ArriVent BioPharma, Inc.'s debt-to-assets increased by 100.0% year-over-year, from 0× to 0×.
- What is the long-term trend for ArriVent BioPharma, Inc.'s debt-to-assets?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s debt-to-assets has grown at a -100.0% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-assets mean?
- Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.